Bridging Global Trade and Healthcare Innovation
Pioneering Cell/Gene Therapy Commercialization & Supply Chain Excellence Across the GCC, MENA, and Beyond
Our Health Care division
Since 2009, Questar Enterprise has redefined the intersection of global trade and healthcare innovation. As a strategic partner to corporations, biotech firms, and governments, we operate at the nexus of three transformative pillars:
1. Advancing Healthcare & Cell/Gene Therapies
Accelerating the commercialization of life-saving therapies by navigating complex regulatory pathways and optimizing clinical development.
2. Driving Innovation in Global Trade
Empowering businesses to source, sell, and procure materials seamlessly across high-growth markets like the UAE, Saudi Arabia, Iraq, and Iran.
3. Simplifying Cross-Border Complexity
Delivering end-to-end solutions for compliance, logistics, and market expansion in regulated industries.
With $1.2B+ in closed deals and a legacy of turning barriers into breakthroughs, Questar is where ambition meets execution.
Our Three-Pillar Mission
Advancing Healthcare & Cell/Gene Therapies
We are catalysts for medical innovation, supporting biotech firms and pharma giants in:
-
Regulatory Mastery: Streamlining approvals across GCC, MENA, FDA, EMA, and WHO frameworks to slash time-to-market by up to 40%.
-
Clinical Trial Optimization: Designing trials for diverse populations, securing ethics approvals, and ensuring compliance with local/global standards.
-
Scalable Manufacturing: Advising on GMP-compliant production, tech transfers, and supply chain resilience for cell/gene therapies.
Example Impact:
Secured EMA and Saudi SFDA approval for a groundbreaking CAR-T therapy in 11 months (industry average: 18+ months).
Revolutionizing Global Trade
From raw materials to finished therapies, we empower businesses with:
Strategic Sourcing: Procuring specialized materials (e.g., bioreactors, single-use systems) at scale from vetted global suppliers.
Market Intelligence: Identifying high-potential markets for therapies or industrial goods using real-time GCC/MENA demand analytics.
Cross-Border Logistics: Managing temperature-controlled shipping, customs clearance, and last-mile delivery for sensitive biotherapeutics.
Simplifying Complexity
Risk Mitigation: Proactive compliance with sanctions (e.g., Iran trade frameworks), export controls, and ESG standards.
Partnership Building: Brokering alliances between biotech innovators and GCC healthcare giants for co-development and distribution.
Core Services
- HEALTH CARE INNOVATION
- Regulatory Strategy & Submissions
- Clinical Trial Design & Site Activation
- Therapy Manufacturing & Cold Chain Logistics
- GLOBAL TRADE SOLUTIONS
- High-Value Procurement ($100M+ deals)
- Market Entry & Distribution Partnerships
- Mega-Project Supply Chain Management
Why Questar?
- Dual Expertise: Rare fusion of healthcare regulatory mastery (FDA, EMA, SFDA) and GCC trade acumen.
- Proven Acceleration: Reduced therapy approval timelines by 30-50% for 15+ biotech clients.
- Global Network: Partnerships with 200+ suppliers, 12+ logistics hubs, and MENA government agencies.
- Ethical Leadership: Certified compliance with international trade and healthcare ethics standards.
Landmark Achievements
- IN HEALTHCARE
- Closed $75M partnership between a U.S. gene therapy startup and UAE healthcare conglomerate.
- Enabled 12 clinical trials across Saudi Arabia and UAE for rare disease therapies.
- IN TRADE
- Executed $220M cross-border logistics deal for Iraq’s Basra Power Plant reconstruction.
- Facilitated $300M in GCC medical device imports for European manufacturers.
Join the Quest for Impact
Whether you’re commercializing a revolutionary therapy or scaling trade operations in the GCC, Questar Enterprise provides the strategic clarity, regulatory firepower, and execution excellence to succeed.
Key Enhancement
This structure positions Questar as a unique, purpose-driven partner for enterprises bridging healthcare innovation and global trade in complex markets.
- Integrated the three-pillar mission into the About Us narrative, balancing healthcare and trade.
- Added specific examples of regulatory approvals, clinical trials, and high-value deals.
- Created distinct service categories for healthcare and trade to showcase dual expertise.
- Emphasized cross-industry impact (e.g., sanctions navigation for pharma, cold-chain logistics for therapies).
- Tailored CTAs and contact info to address both healthcare and trade audiences.
Our Clients
- Americord, New York, NY, USA.
- Regenexx, Broomfield, Colorado, USA.
- Cord for Life, Oldsmar, Florida, USA.
- SmartCells, Dubai, UAE.
- Emirates Integra, Dubai HealthCare City, UAE.
- Dr. Humeira Badsha Center, Dubai, UAE.
- Infohealth FZE, Dubai, UAE.
- Regenerative Outcomes, Nashville, USA.
- Orthobiologix, Mumbai, India.
- Sirona Diagnostics, Mumbai, India.
Client Success Stories
Testimonial
Questar’s regulatory team secured Saudi SFDA approval for our gene therapy in record time. Their MENA expertise is unparalleled
Biotech Innovator
CEO
They navigated Iran-UAE sanctions to procure critical raw materials for our drug manufacturing line, saving us $8M annually.
Global Pharma
Supply Chain Director
OUR HEALTH CARE EXPERTISE
- Asa has 22+ yrs of “Global Leadership” experience, in executing projects, operating, and managing facilities for Biotherapies ( Cell, tissue and gene therapies), Regenerative Medicine, Cord Blood Banks, Apheresis (Blood Products, Plasma Products), Transfusion medicine, Devices, and Transplants.
- Spearheading specialized Cell and Gene Therapy Facilities and Biotech Companies towards achieving highest quality, and compliance.
- Validated subject matter expert- creating, innovating, designing, consulting, and establishing novel technologies in the field of regenerative medicine.
- In her current role she is supporting Biotech companies on Longevity, Anti-Ageing, Cosmetic and Aesthetic Gynecology, Sports Medicine and Orthopedic arena.
- She pursues and attains financial success in all her projects, and has been instrumental in raising multi million dollars ($250-$450 M) for startups.
- Asa speaks 7 languages and is a Certified Advanced Biotherapies (Cell and Gene Therapies) Professional, a Diplomat, and a Fellow of American Board of Regenerative Medicine.
- Other Roles: Board Member SICOT, IARMES, Chair & Co-Chair AABB Committees, Chair AATM CT & UAE Committees,